参考文献/References:
[1] Lloyd-Jones D,Adams R,Carnethon M,et al.Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee[J].Circulation,2009,119(3):e21-181.
[2] Johnston SC.Clinical practice. Transient ischemic attack [J]. N Engl J Med N Engl J Med,2002,347:1687-1692.
[3] Johansson,Olsson T,Carlberg B,et al.Hypercortisolism after stroke-partly cytokine-mediated?[J].J Neurol Sci,1997,147(1):43-47.
[4] Latendresse G,Ruiz RJ.Bioassay research methodology: measuring CRH in pregnancy[J].Biol Res Nurs,2008,10(1):54-62.
[5] Dabla PK,Dabla V,Arora S.Co-peptin: Role as a novel biomarker in clinical practice[J].Clin Chim Acta,2011,412(1/2):22-28.
[6] Katan M,Morgenthaler N,Widmer I,et al.Copeptin,a stable peptide derived from the vasepressin precursor.correlates with tile individual stress level[J].Neuro Endocrinol Lett,2008,29(3):341-346.
[7] Jochberger S,Morgenthaler NG,Mayr VD,et al.Copeptin and arginine vasopressin concentrations in critically ill patients[J].Journal of Clinical Endocrinology & Metabolism,2006,91(11):4381-4386.
[8] Neuhold S,Huelsmann M,Strunk G,et al.Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease[J].J Am Coll Cardiol,2008,52(4):266-272.
[9] Voors AA,Von Haehling S,Anker SD,et al.C-terminal provasopressin(copeptin)is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study[J].Eur Heart J,2009,30(10):1187-1194.
[10] Stefan J,Morgenthaler NG,Viktoria DM,et al.Copeptin and arginine vasopressin concentrations in critically ill patients[J]. The Journal of Clinical Endocrinology & Metabolism,91(11):4381-4386.
[11] Petraglia F,Genazzani AD,Aguzzoli L,et al.Pulsatile fluctuations of plasma-gonadotropin-releasing hormone and corticotropin-releasing factor levels in healthy pregnant women[J].Acta Obstet Gynecol Scand,1994,73(4):284-289.
[12] Evans MJ,Livesey JH,Ellis MJ,et al.Effect of anticoagulants and storage temperatures on stability of plasma and serum hormones[J].Clin Biochem,2001,34(2):107-112.
[13] Katan M,Morgenthaler NG,Dixit KC,et al.Anterior and posterior pituitary function testing with simultaneous insulin tolerance test and a novel copeptin assay[J].Journal of Clinical Endocrinology & Metabolism,2007,92(7):2640-2643.
[14] Holwerda DA.A glycopeptide from the posterior lobe of pig pituitaries. I. Isolation and characterization[J].Eur J Biochem,1972,28(3):334-339.
[15] Morgenthaler NG,Struck J,Jochberger S,et al.Copeptin: clinical use of a new biomarker[J].Trends Endocrinol Metab,2008,19(2):43-49.
[16] Katan M,Fluri F,Morgenthaler NG,et al.Copeptin: a novel, Independent prognostic marker in patients with ischemic stroke[J].Ann Neurol,2009,66(6):799-808.
[17] De Marchis GM,Katan M,Weck A,et al.Copeptin and risk stratification in patients with ischemic stroke and transient ischemic attack: the CoRisk study[J].Int J Stroke,2013,8(3):214-218.
[18] Zhang X,Lu XM,Huang LF,et al.Copeptin is associated with one-year mortality and functional outcome in patients with acute spontaneous basal ganglia hemorrhage[J].Peptides,2012,33(2):336-341.
[19] Zweifel C,Katan M,Schuetz P,et al.Copeptin is associated with mortality and outcome in patients with acute intracerebral hemorrhage[J].BMC Neurol,2010,10:34.
[20] Zhang JL,Yin CH,Zhang Y,et al.Plasma copeptin and long-term outcomes in acute ischemic stroke[J].Acta Neurol Scand,2013,128(6):372-380.
[21] Bassuk SS,Rifai N,Ridker P.High sensitivity C-reactive protein:clinical impoitallee[J].Curr Probl Cardiol,2004,29(8):439-493.
[22] Paseeri Y,Willerson JT,Yeh E,et al.Direct P roinflammatory effect of C-reacetive protein on human endothelial cells[J].Circulation,2000,102:2165-2168.
[23] Yasojima K,Schwab C,Mcgeer EG,et al.Generation of C-reactive protein and complement components in atherosclerotic plaques[J].Am J Pathol,2001,158(3):1039-1051.
[24] 高建国,周农,翟金霞.血清C反应蛋白水平与脑梗死预后的关系[J].临床神经病学杂志,2005,18(1):43-44.
[25] Hamidon BB,Sapiah S,Nawawi H,et al.The prognostic value 0f C-reactive protein(cRP)levels in patients with acute isehaemic stroke[J].Med J Melaysia,2004,59(5):631-637.
[26] Muir KW,Weir CJ,Alwan W,et al.C-reaction protein and oucome after iseheme stroke[J].Lancet,1999,30(5):981.
[27] 郑建琼,杨年安.超敏C反应蛋白水平与急性脑梗死病情的相关性[J].中国临床药理学杂志,2014,30(5):391-393.
[28] Inflammation EM.Ather06elerosis,and stroke[J].Neurologist,2006,12(3):140-148.
[29] Yaghi S,Hinduja A,Bianchi N.The effect of admission hyperglycemia in stroke patients treated with thrombolysis[J].Int J Neurosci,2012,122(11):637-640.
[30] Capes SE,Hunt D,Malmberg K,et al.Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview[J].Stroke,2001,32(10):2426-2432.
[31] Moulin T,Tatu L,Cr pin-Leblond T,et al.The besan on stroke registry: an acute stroke registry of 2,500 consecutive patients[J].Eur Neurol,1997,38(1):10-20.
[32] Bruno AH.For the TOAST investigators.acute blood glucose level and outcome from ischemie stroke[J].Neurology,1999,52:280-284.
[33] Wu A,Morris DL,Fletcher DR,et al.Analysis of the albumin Cobalt binding(ACBTM)test 8s an adjunct to cardiactroponin I for the early detection of acute myocardial infarction[J].Cardiovaacular Toxicology,2001,1(2):147-151.
[34] Bar-Or D,Lau E,Winkler JV.A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia - A preliminary report[J].Journal of Emergency Medicine,2000,19(4):311-315.
[35] Anwaruddin S,Januzzi JL,Baggish AL,et al.Ischemia-modified albumin improves the usefulness of standard cardiac biomarkers for the diagnosis of myocardial ischemia in the emergency department setting[J].Am J Clin Pathol,2005,123(1):140-145.
[36] Abboud H,Labreuche J,Meseguer E,et al.Ischemia-modified albumin in acute stroke[J].Cerebrovascular Diseases,2007,23(2/3):216-220.
[37] Maas MB,Furie KL.Molecular biomarkers in stroke diagnosis andprognosis[J].Biomark Med,2009,3(4):363-383.
[38] 陈家强,龚道元,李炜煊,等.IMA、IL-6与缺血性脑卒中脑梗死体积的相关研究[J].医学检验与临床,2010,21(4):43-45.
[39] Abboud H,Labreuche J,Meseguer E,et al.Ischemia-modified albumin in acute stroke[J].Cerebrovascular Diseases,2007,23(2/3):216-220.
[40] 李雪莲,朱飞奇,陈俊斌,等.血清缺血修饰白蛋白与急性脑梗死的早期预后关系[J].中国医师杂志,2014,16(2):259-260.
[41] Han K,Jia N,Yang L,et al.Correlation between ischemia-modified albumin and lipid levels in patients with acute cerebrovascular disease[J].Mol Med Rep,2012,6(3):621-624.
[42] Mudd SH,Finkelstein JD,Refsum H,et al.Homocysteine and its disulfide derivatives: a suggested consensus terminology[J].Arterioscler Thromb Vasc Biol,2000,20(7):1704-1706.
[43] Malinow Mr BA,Ine D.And cardiovascular disease:a statement for healthcare professionals from the nutrition committee,American heart association[J].Circulation,1999,99(1):178-182.
[44] 马菊香,李京晔.脑卒中患者血浆同型半胱氨酸水平升高临床意义[J].中国实用神经疾病杂志,2011,14(8):28-29.
[45] Wald DS,Law M,Morris JK.Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis[J].BMJ,2002,325(7374):1202.
[46] Yoo JH,Choi GD,Kang SS.Pathogenicity of thermolabile methylenetetrahydrofolate reductase for vascular dementia[J].Arterioscler Thromb Vasc Biol,2000,20(8):1921-1925.
[47] Abdulle AM,Pathan JY,Moussa N,et al.Association between homocysteine and endothelial dysfunction markers in stroke disease[J].Nutr Neurosci,2010,13(1):2-6.
[48] 陈春暖,黄金莎,王涛.脑血管病患者血浆中同型半胱氨酸的丰度及相关性研究[J].卒中与神经疾病,2011,18(1):13-16.
[49] 刘晓红,夏菁,周维智.同型半胱氨酸、超敏C反应蛋白水平及颈动脉粥样硬化与老年脑梗死的关系[J].卒中与神经疾病,2011,18(6):379-381.
[50] 张秀清,曲永霞,吕建强,等.急性脑梗塞面积与血小板及 WBC 数的相关分析[J].临床神经病学杂志,1993,6(1):20.
[51] 曹霞,曹丙振,薛慎伍,等.急性缺血性脑血管病血小板与白细胞计数相关性研究[J].脑与神经疾病杂志,1994,2(3):164-165.
[52] Oppenheimer SM.Plasma cortisol as a measure of stress response in acute stroke[Z],1990:1376.
[53] Jiang D,Zc D.Reaction of leukocytes in acute stage of stroke and implication[J]. J TongJi Univ,2001,30(6):593-594.
[54] 王炳旭,刘凤玲,韩仲岩.缺血性脑血管病患者的外周血白细胞昼夜节律性变化[J].临床神经病学杂志,1996,9(3):40-42.
[55] 姜亚军.综述[J].脑缺血再灌注期间白细胞粘附机制的研究进展. 国外医学脑血管疾病分册,1996,4(5):262.
[56] 龙海泳,汲晶.脑梗死患者急性期白细胞计数、中性粒细胞比率、红细胞沉降率的临床研究[J].中国神经免疫学和神经病学杂志,2015,22(2):143-146, 55.
[57] Logov S.Intimal hyperplasia,vascular modeling and the restenosis problem[J].Circulation,1994,89:2888-2892.
[58] Pozzilli C,Lenzi GL,Argentino C,et al.Peripheral white blood cell count in cerebral ischemic infarction[J].Acta Neurol Scand,1985,71(5):396-400.
[59] Turaj W,Sowik A,Dziedzic T,et al.Increased plasma fibrinogen predicts one-year mortality in patients with acute ischemic stroke[J].J Neurol Sci,2006,246(1/2):13-19.
[60] 蓝顶琴,蓝宝林.急性脑血管病外周血白细胞变化的观察[J].临床神经病学杂志,1995,8(4):205.
[61] 叶家楷,张金涛,孔艳,等.白细胞计数、中性粒细胞比率和红细胞沉降率与急性脑梗死结局的关系[J].中华流行病学杂志,2012,33(9):956-960.
[62] Rosenberg GA,Estrada EY,Dencoff JE.Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain[J].Stroke,1998,29(10):2189-2195.
[63] 周元林,蒋辉华,张丹红,等.急性脑梗死患者血清MMP-9及TI M P-1的表达及意义[J].浙江医学,2009,2:155-157.
[64] 王梅.D-二聚体检测的临床应用进展[J].国际检验医学杂志,2011,32(1):82-84.
[65] 詹海涛,黄峰,陈钢.重症脑梗死患者血浆D-二聚体测定的临床意义[J].中国现代医学杂志,2008,18(1):105-107.
[66] 侯新丽.血浆D-二聚体定量检测在脑梗死诊治中的临床价值[J].山东医药,2005,45(20):59-60.
[67] 刘家敏,于吉友,刘斌,等.急性脑梗死患者血浆NSE、D-二聚体的动态监测的临床研究[J].脑与神经疾病杂志,2014,22(6):460-463.